These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 12884349)

  • 41. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.
    Righetti SC; Perego P; Corna E; Pierotti MA; Zunino F
    Cell Growth Differ; 1999 Jul; 10(7):473-8. PubMed ID: 10437915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGFR codon 497 polymorphism - implications for receptor sensitivity to inhibitors in HNSCC cell lines.
    Krohn V; Wiegand S; Werner JA; Mandic R
    Anticancer Res; 2011 Jan; 31(1):59-65. PubMed ID: 21273581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
    Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K; Schlien S; Bosch FX
    J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK; Zanation AM; Moss JR; Yarbrough WG
    Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
    Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
    Ai Zheng; 2003 Nov; 22(11):1140-6. PubMed ID: 14613640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S; Cvetkovska E; Westin T; Young C
    Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
    Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function.
    Céraline J; Deplanque G; Noël F; Natarajan-Amé S; Bergerat JP; Klein-Soyer C
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):91-5. PubMed ID: 12497212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
    Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.
    Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H
    Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM
    Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
    Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
    Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
    Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
    Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of wild-type p53 gene on the chemotherapy sensitivity of ovarian cancer SKOV-3 cells to cisplatin].
    Jin Z; Guan T; Li S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):218-20. PubMed ID: 12048682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.